APA   Click to copy
X, Z., T, W., X, Z., Y, L., M, L., Z, H., … R, S. (2023). GMP development and preclinical validation of CAR-T cells targeting a lytic EBV antigen for therapy of EBV-associated malignancies. Frontiers in Immunology, 14. https://doi.org/10.3389

Chicago/Turabian   Click to copy
X, Zhang, Wang T, Zhu X, Lu Y, Li M, Huang Z, Han D, et al. “GMP Development and Preclinical Validation of CAR-T Cells Targeting a Lytic EBV Antigen for Therapy of EBV-Associated Malignancies.” Frontiers in Immunology 14 (2023).

MLA   Click to copy
X, Zhang, et al. “GMP Development and Preclinical Validation of CAR-T Cells Targeting a Lytic EBV Antigen for Therapy of EBV-Associated Malignancies.” Frontiers in Immunology, vol. 14, fimmu.2023.1103695. PMID: 36817460; PMCID: PMC9932894, 2023, doi:10.3389.

@article{zhang2023a,
  title = {GMP development and preclinical validation of CAR-T cells targeting a lytic EBV antigen for therapy of EBV-associated malignancies},
  year = {2023},
  journal = {Frontiers in Immunology},
  volume = {14},
  doi = {10.3389},
  author = {X, Zhang and T, Wang and X, Zhu and Y, Lu and M, Li and Z, Huang and D, Han and L, Zhang and Y, Wu and L, Li and F, Klawonn and R, Stripecke},
  howpublished = {fimmu.2023.1103695. PMID: 36817460; PMCID: PMC9932894}
}